Hutch News

Hutch News

Stories tagged 'clinical trials'

Structural and clinical barriers keep 3 of 4 cancer patients from participating in trials

‘Patients are willing to participate in trials if they’re offered one’

Feb. 19, 2019 | By Diane Mapes / Fred Hutch News Service

View story >


How to boost cancer clinical trial participation

New study suggests loosening strict comorbidity criteria would open trials to thousands of previously exempt patients

Jan. 10, 2019 | By Diane Mapes / Fred Hutch News Service

Low clinical trial participation is a problem that’s plagued cancer research for decades, with most estimates putting adult cancer patient involvement at less than 5 percent. Fred Hutch's Dr. Joseph Unger, a biostatistician whose research focuses on improving access to trials, led a new study on how comorbidities squelch patient participation -- and what we might be able to do about it.

View story >


'Exciting' but early results in trial of immunotherapy for myeloma

Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease

Dec. 3, 2018 | by Susan Keown / Fred Hutch News Service

The patients were out of options to treat their advanced myelomas. Then, they enrolled on a new clinical trial of genetically reprogrammed immune cells called CAR T cells.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.